Si Yeol Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Si Yeol Kim has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Jae Pil Shin
Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Korea
6 shared publicationsDong Ho Park
Kyungpook National University
3 shared publicationsD H Park
Department of Ophthalmology, School of Medicine, Kyungpook National University, Chung-gu, Daegu, South Korea
2 shared publicationsJ P Shin
Department of Ophthalmology, School of Medicine, Kyungpook National University, Chung-gu, Daegu, South Korea
2 shared publicationsHan Sang Park
Nune Eye Hospital, 18-21F LIG Bldg, 2397, Dalgubeol-daero, Suseong-gu, Daegu, Republic of Korea
1 shared publicationHong Kyun Kim
Kyungpook National University
1 shared publication
Latest Publications
- 26 February 2015
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 253 (12) , 2129-2135
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy
To investigate the short-term efficacy of subthreshold micropulse yellow laser photocoagulation in the treatment of chronic central serous chorioretinopathy (CSC). A retrospective case series study was performed from April 2012 to June 2014 at Nune Eye Hospital. A total of ten eyes of ten chronic or chronic recurrent CSC patients received subthreshold micropulse yellow laser photocoagulation with a 15 % duty cycle at a reduced energy level from the micropulse laser test burn. Laser exposure time was 20 ms, and the spot diameter was 100 μm. Patients were followed up at the authors’ hospital for at least 3 months. Mean age of patients was 43.9 years. The baseline best-corrected visual acuity was 0.21 ± 0.21 logarithm of the minimum angle of resolution (logMAR), which was improved to 0.055 ± 0.093 logMAR (p = 0.020) at the 3-month follow-up and 0.035 ± 0.063 logMAR (p = 0.012) at final follow-up. Central macular thickness at baseline was 349.2 ± 53.2 μm, which was changed to 250.7 ± 28.8 μm (p = 0.009) at the 3-month follow-up and 261.2 ± 38.31 μm (p = 0.009) at final follow-up. Subthreshold micropulse yellow laser photocoagulation showed short-term efficacy in treating chronic CSC without retinal damage. However, prospective, randomized, and comparative large-scale studies are needed to evaluate the efficacy and safety of this treatment.
- 26 February 2015
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 253 (12) , 2129-2135
Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy
To investigate the short-term efficacy of subthreshold micropulse yellow laser photocoagulation in the treatment of chronic central serous chorioretinopathy (CSC). A retrospective case series study was performed from April 2012 to June 2014 at Nune Eye Hospital. A total of ten eyes of ten chronic or chronic recurrent CSC patients received subthreshold micropulse yellow laser photocoagulation with a 15 % duty cycle at a reduced energy level from the micropulse laser test burn. Laser exposure time was 20 ms, and the spot diameter was 100 μm. Patients were followed up at the authors’ hospital for at least 3 months. Mean age of patients was 43.9 years. The baseline best-corrected visual acuity was 0.21 ± 0.21 logarithm of the minimum angle of resolution (logMAR), which was improved to 0.055 ± 0.093 logMAR (p = 0.020) at the 3-month follow-up and 0.035 ± 0.063 logMAR (p = 0.012) at final follow-up. Central macular thickness at baseline was 349.2 ± 53.2 μm, which was changed to 250.7 ± 28.8 μm (p = 0.009) at the 3-month follow-up and 261.2 ± 38.31 μm (p = 0.009) at final follow-up. Subthreshold micropulse yellow laser photocoagulation showed short-term efficacy in treating chronic CSC without retinal damage. However, prospective, randomized, and comparative large-scale studies are needed to evaluate the efficacy and safety of this treatment.
- 19 August 2011
- Published by Springer Nature in Eye
- Vol. 25 (11) , 1465-1470
Conjunctival pigmentation after 23-gauge microincisional vitrectomy surgery
Aim Methods Results Conclusions
- 19 August 2011
- Published by Springer Nature in Eye
- Vol. 25 (11) , 1465-1470
Conjunctival pigmentation after 23-gauge microincisional vitrectomy surgery
Aim Methods Results Conclusions
- 15 July 2011
- Published by Springer Nature in Eye
- Vol. 25 (10) , 1327-1332
Combined 23-gauge microincisonal vitrectomy surgery and phacoemulsification with AcrySof toric intraocular lens implantation: a comparative study
Aim Methods Results Conclusions
- 15 July 2011
- Published by Springer Nature in Eye
- Vol. 25 (10) , 1327-1332
Combined 23-gauge microincisonal vitrectomy surgery and phacoemulsification with AcrySof toric intraocular lens implantation: a comparative study
Aim Methods Results Conclusions
- Open Access
- 1 January 2011
- Published by Korean Ophthalmological Society in Korean Journal of Ophthalmology
- Vol. 25 (3) , 218-221
A Case of Intravitreal Bevacizumab Injection for the Treatment of Choroidal Neovascularization in Angioid Streaks
Lee JW, et al. Korean J Ophthalmol. 2011 Jun;25(3):218-221. https://doi.org/10.3341/kjo.2011.25.3.218
- 1 January 2011
- Published by Korean Ophthalmological Society in Korean Journal of Ophthalmology
- Vol. 25 (3) , 218-221
Open AccessA Case of Intravitreal Bevacizumab Injection for the Treatment of Choroidal Neovascularization in Angioid Streaks
Lee JW, et al. Korean J Ophthalmol. 2011 Jun;25(3):218-221. https://doi.org/10.3341/kjo.2011.25.3.218
- 1 May 2010
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 54 (3) , 244-246
Conjunctival nevus-like lesions originating from a sclerotomy site after 23-gauge transconjunctival sutureless vitrectomy
- 1 May 2010
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 54 (3) , 244-246
Conjunctival nevus-like lesions originating from a sclerotomy site after 23-gauge transconjunctival sutureless vitrectomy
- 12 December 2009
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 248 (5) , 641-650
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
To study the clinical outcome and complications of intravitreal bevacizumab (IVB) versus triamcinolone acetonide (IVT) injections at the end of vitrectomy in patients with diabetic vitreous hemorrhage. This is a retrospective comparative case study comprised of 156 eyes from 139 consecutive patients who underwent pars plana vitrectomy for diabetic vitreous hemorrhage (VH) with or without tractional retinal detachment (TRD). IVB (1.25 mg/0.05 ml) injection was done for 66 eyes (60 patients) and IVT (4 mg/0.1 ml) injection for 33 eyes (31 patients) at the end of vitrectomy, and no injection was done for 57 eyes (48 patients). Main outcome measures were best-corrected visual acuity (BCVA), intraocular pressure (IOP), and incidence of postoperative VH and reoperation with at least 12 months of follow-up. Early postoperative VH within 1 month postoperatively occurred in eight eyes (12.1%) from the IVB group, three eyes (9.1%) from the IVT group, and 21 eyes (36.8%) from the control group. The rate of early postoperative VH was significantly lower in the IVB and IVT group than the control group (p = 0.002 and 0.006, respectively). Late postoperative VH after 1 month postoperatively occurred in 11 eyes (16.7%) from the IVB group, three eyes (9.1%) from the IVT group, and 12 eyes (21.1%) from the control group. There was no difference between the three groups (P = 0.341). BCVA of the IVB, IVT, and control group at postoperative months 1, 3, 6, 9, and 12 significantly improved from the preoperative BCVA (p < 0.01, respectively). There was no difference for BCVA between the three groups at each follow-up period (p > 0.05). In only the IVT group, IOP at postoperative day 1 was higher than IOP preoperatively (p = 0.002). There was no significant difference in the rate of reoperation between the three groups (p = 0.275). IVB and IVT injection at the end of diabetic vitrectomy is a useful adjunctive therapy for reducing early postoperative VH compared to the control group. IVB injection does not have a risk of a temporary rise of IOP, which the IVT group has.
- 12 December 2009
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 248 (5) , 641-650
Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study
To study the clinical outcome and complications of intravitreal bevacizumab (IVB) versus triamcinolone acetonide (IVT) injections at the end of vitrectomy in patients with diabetic vitreous hemorrhage. This is a retrospective comparative case study comprised of 156 eyes from 139 consecutive patients who underwent pars plana vitrectomy for diabetic vitreous hemorrhage (VH) with or without tractional retinal detachment (TRD). IVB (1.25 mg/0.05 ml) injection was done for 66 eyes (60 patients) and IVT (4 mg/0.1 ml) injection for 33 eyes (31 patients) at the end of vitrectomy, and no injection was done for 57 eyes (48 patients). Main outcome measures were best-corrected visual acuity (BCVA), intraocular pressure (IOP), and incidence of postoperative VH and reoperation with at least 12 months of follow-up. Early postoperative VH within 1 month postoperatively occurred in eight eyes (12.1%) from the IVB group, three eyes (9.1%) from the IVT group, and 21 eyes (36.8%) from the control group. The rate of early postoperative VH was significantly lower in the IVB and IVT group than the control group (p = 0.002 and 0.006, respectively). Late postoperative VH after 1 month postoperatively occurred in 11 eyes (16.7%) from the IVB group, three eyes (9.1%) from the IVT group, and 12 eyes (21.1%) from the control group. There was no difference between the three groups (P = 0.341). BCVA of the IVB, IVT, and control group at postoperative months 1, 3, 6, 9, and 12 significantly improved from the preoperative BCVA (p < 0.01, respectively). There was no difference for BCVA between the three groups at each follow-up period (p > 0.05). In only the IVT group, IOP at postoperative day 1 was higher than IOP preoperatively (p = 0.002). There was no significant difference in the rate of reoperation between the three groups (p = 0.275). IVB and IVT injection at the end of diabetic vitrectomy is a useful adjunctive therapy for reducing early postoperative VH compared to the control group. IVB injection does not have a risk of a temporary rise of IOP, which the IVT group has.
- 14 May 2009
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 247 (10) , 1331-1337
Surgically induced astigmatism in combined phacoemulsification and vitrectomy; 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge standard vitrectomy
To study the surgically induced astigmatism (SIA) in combined phacoemulsification with 23-gauge transconjunctival sutureless vitrectomy (TSV) versus combined phacoemulsification with 20-gauge standard vitrectomy. This is a prospective comparative study comprised of 40 eyes from 37 consecutive patients. Twenty eyes (19 patients) underwent combined phacoemulsification and 23-gauge TSV, and 20 eyes (18 patients) underwent combined phacoemulsification and 20-gauge standard vitrectomy. Corneal topography was obtained preoperatively and postoperatively at weeks 1, 4, 8, and 12. Main outcome measurement was SIA consisting of astigmatic amplitude and axis from cross cylinder form calculated by rectangular coordinate method using the Holladay-Cravy-Koch formula. The mean SIA was 1.07 ± 0.57 diopters (D) in the 23-gauge TSV group and 2.09 ± 0.81 D in the 20-gauge group at postoperative week 1. SIA of both groups at weeks 4, 8, and 12 significantly decreased from the SIA at postoperative week 1 (p < 0.0001 for all 3 weeks). SIA of the 23-gauge TSV group was significantly less than that of the 20-gauge standard vitrectomy group at each postoperative period (p = 0.001). SIA of the gas tamponade group in the 23-gauge TSV was significantly greater than that of the non-gas tamponade group at postoperative week one (p = 0.039). Shifts of axis to other meridians returned to preoperative meridian in 12 eyes (85.7%) for the 23-gauge group and seven eyes (43.8%) for the 20-gauge group. Combined phacoemulsification and pars plana vitrectomy (23-gauge and 20-gauge) could induce significant SIA at postoperative week 1, and decrease over 3 months. However, 23-gauge TSV showed less SIA and early stabilization compared to the 20-gauge standard vitrectomy.
- 14 May 2009
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 247 (10) , 1331-1337
Surgically induced astigmatism in combined phacoemulsification and vitrectomy; 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge standard vitrectomy
To study the surgically induced astigmatism (SIA) in combined phacoemulsification with 23-gauge transconjunctival sutureless vitrectomy (TSV) versus combined phacoemulsification with 20-gauge standard vitrectomy. This is a prospective comparative study comprised of 40 eyes from 37 consecutive patients. Twenty eyes (19 patients) underwent combined phacoemulsification and 23-gauge TSV, and 20 eyes (18 patients) underwent combined phacoemulsification and 20-gauge standard vitrectomy. Corneal topography was obtained preoperatively and postoperatively at weeks 1, 4, 8, and 12. Main outcome measurement was SIA consisting of astigmatic amplitude and axis from cross cylinder form calculated by rectangular coordinate method using the Holladay-Cravy-Koch formula. The mean SIA was 1.07 ± 0.57 diopters (D) in the 23-gauge TSV group and 2.09 ± 0.81 D in the 20-gauge group at postoperative week 1. SIA of both groups at weeks 4, 8, and 12 significantly decreased from the SIA at postoperative week 1 (p < 0.0001 for all 3 weeks). SIA of the 23-gauge TSV group was significantly less than that of the 20-gauge standard vitrectomy group at each postoperative period (p = 0.001). SIA of the gas tamponade group in the 23-gauge TSV was significantly greater than that of the non-gas tamponade group at postoperative week one (p = 0.039). Shifts of axis to other meridians returned to preoperative meridian in 12 eyes (85.7%) for the 23-gauge group and seven eyes (43.8%) for the 20-gauge group. Combined phacoemulsification and pars plana vitrectomy (23-gauge and 20-gauge) could induce significant SIA at postoperative week 1, and decrease over 3 months. However, 23-gauge TSV showed less SIA and early stabilization compared to the 20-gauge standard vitrectomy.
- Open Access
- 1 January 2008
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 49 (2) , 333-339
Ocular Concentration after Subtenon and Intravitreal Injection of Triamcinolone Acetonide in Rabbits
Park YW, et al. J Korean Ophthalmol Soc. 2008 Feb;49(2):333-339. http://dx.doi.org/10.3341/jkos.2008.49.2.333
- 1 January 2008
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 49 (2) , 333-339
Open AccessOcular Concentration after Subtenon and Intravitreal Injection of Triamcinolone Acetonide in Rabbits
Park YW, et al. J Korean Ophthalmol Soc. 2008 Feb;49(2):333-339. http://dx.doi.org/10.3341/jkos.2008.49.2.333
- Open Access
- 1 January 2008
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 49 (1) , 81-90
Intravitreal Versus Subtenon Injections of Triamcinolone Acetonide for Diabetic Macular Edema
Kwon SJ, et al. J Korean Ophthalmol Soc. 2008 Jan;49(1):81-90. http://dx.doi.org/10.3341/jkos.2008.49.1.81
- 1 January 2008
- Published by Korean Ophthalmological Society in Journal of the Korean Ophthalmological Society
- Vol. 49 (1) , 81-90
Open AccessIntravitreal Versus Subtenon Injections of Triamcinolone Acetonide for Diabetic Macular Edema
Kwon SJ, et al. J Korean Ophthalmol Soc. 2008 Jan;49(1):81-90. http://dx.doi.org/10.3341/jkos.2008.49.1.81